Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Proc Natl Acad Sci U S A ; 107(25): 11549-54, 2010 Jun 22.
Artículo en Inglés | MEDLINE | ID: mdl-20534540

RESUMEN

Hepatitis C virus (HCV) infection is associated with dysregulation of both lipid and glucose metabolism. As well as contributing to viral replication, these perturbations influence the pathogenesis associated with the virus, including steatosis, insulin resistance, and type 2 diabetes. AMP-activated protein kinase (AMPK) plays a key role in regulation of both lipid and glucose metabolism. We show here that, in cells either infected with HCV or harboring an HCV subgenomic replicon, phosphorylation of AMPK at threonine 172 and concomitant AMPK activity are dramatically reduced. We demonstrate that this effect is mediated by activation of the serine/threonine kinase, protein kinase B, which inhibits AMPK by phosphorylating serine 485. The physiological significance of this inhibition is demonstrated by the observation that pharmacological restoration of AMPK activity not only abrogates the lipid accumulation observed in virus-infected and subgenomic replicon-harboring cells but also efficiently inhibits viral replication. These data demonstrate that inhibition of AMPK is required for HCV replication and that the restoration of AMPK activity may present a target for much needed anti-HCV therapies.


Asunto(s)
Proteínas Quinasas Activadas por AMP/metabolismo , Antivirales/farmacología , Genoma Viral , Hepacivirus/genética , Hepatitis C/virología , Lípidos/genética , Proteínas Quinasas Activadas por AMP/antagonistas & inhibidores , Genotipo , Glucosa/metabolismo , Hepatitis C/metabolismo , Humanos , Microscopía Confocal/métodos , Modelos Biológicos , Fosforilación , Transducción de Señal , Replicación Viral
2.
Proc Natl Acad Sci U S A ; 106(37): 15903-8, 2009 Sep 15.
Artículo en Inglés | MEDLINE | ID: mdl-19717445

RESUMEN

An estimated 3% of the global population are infected with hepatitis C virus (HCV), and the majority of these individuals will develop chronic liver disease. As with other chronic viruses, establishment of persistent infection requires that HCV-infected cells must be refractory to a range of pro-apoptotic stimuli. In response to oxidative stress, amplification of an outward K(+) current mediated by the Kv2.1 channel, precedes the onset of apoptosis. We show here that in human hepatoma cells either infected with HCV or harboring an HCV subgenomic replicon, oxidative stress failed to initiate apoptosis via Kv2.1. The HCV NS5A protein mediated this effect by inhibiting oxidative stress-induced p38 MAPK phosphorylation of Kv2.1. The inhibition of a host cell K(+) channel by a viral protein is a hitherto undescribed viral anti-apoptotic mechanism and represents a potential target for antiviral therapy.


Asunto(s)
Apoptosis/fisiología , Hepacivirus/fisiología , Hepacivirus/patogenicidad , Canales de Potasio Shab/antagonistas & inhibidores , Proteínas no Estructurales Virales/fisiología , 2,2'-Dipiridil/análogos & derivados , 2,2'-Dipiridil/farmacología , Línea Celular , Disulfuros/farmacología , Hepacivirus/genética , Hepatitis C Crónica/metabolismo , Hepatitis C Crónica/virología , Humanos , Estrés Oxidativo , Canales de Potasio Shab/efectos de los fármacos , Canales de Potasio Shab/metabolismo , Proteínas no Estructurales Virales/genética , Proteínas Quinasas p38 Activadas por Mitógenos/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA